18. 脊髄小脳変性症(多系統萎縮症を除く。) Spinocerebellar degeneration Clinical trials / Disease details


臨床試験数 : 71 薬物数 : 101 - (DrugBank : 30) / 標的遺伝子数 : 45 - 標的パスウェイ数 : 65

  
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2009-010865-22-IT
(EUCTR)
06/05/200916/04/2009An open-label, single treatment, safety and efficacy, long-term study of deferiprone in subjects with Friedreich?s ataxia - NDAn open-label, single treatment, safety and efficacy, long-term study of deferiprone in subjects with Friedreich?s ataxia - ND patients affected by Friedreich AtaxiaINN or Proposed INN: DeferiproneAPOPHARMA INC., TORONTO, ONTARIONULLNot RecruitingFemale: yes
Male: yes
74Belgium;France;Spain;Italy
2EUCTR2007-003331-23-IT
(EUCTR)
16/07/200810/07/2008A study investigating the safety and tolerability of deferiprone in patients with Friedreich's Ataxia - NDA study investigating the safety and tolerability of deferiprone in patients with Friedreich's Ataxia - ND patients affected by Friedreich Ataxia
MedDRA version: 9.1;Level: LLT;Classification code 10017374;Term: Friedreich's ataxia
Product Name: Deferiprone
INN or Proposed INN: Deferiprone
APOPHARMA INC., TORONTO, ONTARIONULLNot RecruitingFemale: yes
Male: yes
80United Kingdom;Belgium;France;Spain;Italy